EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches

Biswajit Naik iD, Welka Sahu iD, Guneswar Sethi, Cherish Prashar iD, Gajendra Mohan Baldodiya iD, Jyoti Poswal iD, Chandi C Mandal iD, Jeong Ho Hwang iD, Kailash C Panday, K Sony Reddy iD, Dhaneswar Prusty iD

Chemical Biology & Drug Design · 2026-07 · 108 (1)

DOI: 10.1111/cbdd.70364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 21.07.2026. Verfasst von Biswajit Naik und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, DNA Gyrase, Topoisomerase II Inhibitors. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global spread of drug‐resistant Plasmodium falciparum , particularly artemisinin‐resistant strains, underscores the urgent need for novel antimalarial agents with distinct mechanisms of action and improved therapeutic potential. In this study, we employed an integrated in silico and in vitro strategy to identify compounds with inhibitory activity against P. falciparum apicoplast Gyrase B (PfGyrB). High‐throughput virtual screening identified hit compounds with favorable predicted interactions against the target protein, which were subsequently evaluated using biochemical ATPase inhibition and parasite growth inhibition assays. UNC8153 and Fexofenadine hydrochloride demonstrated time‐dependent antiplasmodial activity, with lower IC 50 values at 96 h than at 48 h under prolonged exposure conditions. UNC8153 exhibited greater antiplasmodial activity (~25‐fold) than the reference compound novobiocin during the second intraerythrocytic cycle. Morphological analysis indicated impaired parasite development during the second intraerythrocytic cycle under prolonged exposure conditions. Importantly, UNC8153 retained inhibitory activity against the artemisinin‐resistant C580Y strain and exhibited minimal cytotoxicity toward HEK‐293 cells under the tested experimental conditions. Structural similarity analysis indicated that the identified compounds are chemically distinct from currently used antimalarial drugs, supporting their structural novelty. Collectively, these findings identify UNC8153 as a structurally distinct new antiplasmodial scaffold warranting further mechanistic, pharmacological, and in vivo evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumAntimalarialsDNA GyraseTopoisomerase II InhibitorsHumansHEK293 CellsDrug DiscoveryMolecular Docking SimulationDrug ResistanceProtozoan Proteins

Stichwörter der Autor:innen

Gyrase B inhibitorsantimalarial drug discoverydrug resistancemalariaplasmodium falciparum

Substanzen

AntimalarialsDNA GyraseTopoisomerase II InhibitorsProtozoan Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.
  • School of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar, Odisha, India.
  • Animal Biotechnology and Genomics Division, National Institute of Animal Science, Rural Development Administration, Jeonbuk State, Republic of Korea.
  • ICMR-National Institute of Malaria, New Delhi, India.
  • Academy of Scientific and Innovative Research (AcSIR), Gaziabad, India.
  • Department of Animal Science and Technology, Konkuk University, Seoul, Republic of Korea.

ORCID-Profile: Biswajit Naik, Welka Sahu, Cherish Prashar, Gajendra Mohan Baldodiya, Jyoti Poswal, Chandi C Mandal, Jeong Ho Hwang, K Sony Reddy, Dhaneswar Prusty

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Naik, B., Sahu, W., Sethi, G., Prashar, C., Baldodiya, G. M., Poswal, J., Mandal, C. C., Hwang, J. H., Panday, K. C., Reddy, K. S., & Prusty, D. (2026). Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70364

Vancouver

Naik B, Sahu W, Sethi G, Prashar C, Baldodiya GM, Poswal J, et al. Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70364

BibTeX
@article{Naik2026,
  author = {Naik, Biswajit and Sahu, Welka and Sethi, Guneswar and Prashar, Cherish and Baldodiya, Gajendra Mohan and Poswal, Jyoti and Mandal, Chandi C and Hwang, Jeong Ho and Panday, Kailash C and Reddy, K Sony and Prusty, Dhaneswar},
  title = {Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {1},
  doi = {10.1111/cbdd.70364}
}
Kostenlos starten →